ANKELIFE specializes in the research, development, and production of genetic engineering drugs in the cosmetics field.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 2, 2017 | Series B | ¥20M | 1 | Hefei Hi-Tech Venture Capital | — | Detail |
Oct 14, 2016 | Series A | ¥10M | 1 | Zhongan Health | — | Detail |
Oct 27, 2015 | Angel | ¥3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hefei Hi-Tech Venture Capital | Yes | Series B |
Zhongan Health | Yes | Series A |
Hefei Ke Chuang | — | Angel |